Patents by Inventor Corinne Breque

Corinne Breque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8153114
    Abstract: The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.
    Type: Grant
    Filed: August 24, 2011
    Date of Patent: April 10, 2012
    Assignee: Cytheris
    Inventors: Michel Morre, Brigitte Assouline, Iann Rance, Anne Gregoire, Corinne Breque
  • Publication number: 20120016104
    Abstract: The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.
    Type: Application
    Filed: August 24, 2011
    Publication date: January 19, 2012
    Applicant: CYTHERIS
    Inventors: Michel Morre, Brigitte Assouline, Iann Rance, Anne Gregoire, Corinne Breque
  • Patent number: 8034327
    Abstract: The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: October 11, 2011
    Assignee: Cytheris
    Inventors: Michel Morre, Brigitte Assouline, Iann Rance, Anne Gregoire, Corinne Breque
  • Publication number: 20100196312
    Abstract: The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.
    Type: Application
    Filed: February 24, 2010
    Publication date: August 5, 2010
    Applicant: CYTHERIS
    Inventors: Michel Morre, Brigitte Assouline, Iann Rance, Anne Gregoire, Corinne Breque
  • Patent number: 7708985
    Abstract: The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.
    Type: Grant
    Filed: July 19, 2006
    Date of Patent: May 4, 2010
    Assignee: CYTHERIS
    Inventors: Michel Morre, Brigitte Assouline, Iann Rance, Anne Gregoire, Corinne Breque
  • Publication number: 20080206190
    Abstract: The present invention relates to new and improved interleukin-7 polypeptides, as well as compositions comprising the same, their preparation and uses. The invention more particularly relates to hyperglycosylated IL-7 polypeptides having improved properties, as well as their manufacture and therapeutic uses. The invention also discloses novel IL-7 polypeptides having modified amino acid sequences containing artificially created glycosylation site(s), as well as corresponding nucleic acid molecules, vectors and recombinant host cells. The invention also relates to the use of such polypeptides, cells or nucleic acids for curative or preventive treatment of mammalian subjects, including human subjects.
    Type: Application
    Filed: July 19, 2006
    Publication date: August 28, 2008
    Applicant: CYTHERIS
    Inventors: Michel Morre, Brigitte Assouline, Iann Rance, Anne Gregoire, Corinne Breque